New Century Financial Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,062
Closed -$297K 67
2025
Q2
$297K Sell
1,062
-84
-7% -$23.8K 0.35% 66
2025
Q1
$357K Sell
1,146
-1,870
-62% -$552K 0.41% 82
2024
Q4
$788K Sell
3,016
-584
-16% -$173K 0.33% 79
2024
Q3
$1.16M Buy
3,600
+386
+12% +$126K 0.43% 60
2024
Q2
$1M Buy
3,214
+151
+5% +$44.4K 0.43% 64
2024
Q1
$871K Buy
3,063
+159
+5% +$46.5K 0.6% 54
2023
Q4
$836K Buy
+2,904
New +$791K 0.72% 39

Other funds holding AMGN

New Century Financial Group's AMGN Position: Q3 2025 in Review

New Century Financial Group sold out of Amgen (AMGN) in Q3 2025, closing a stake of 1,062 shares — an estimated $297K sold.

New Century Financial Group first reported a position in AMGN in Q4 2023 and held it in 7 quarters. The position peaked at $1.16M in Q3 2024. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • New Century Financial Group reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
  • New Century Financial Group sold 1,062 Amgen shares in Q3 2025, an estimated $297K.
  • New Century Financial Group first reported a position in Amgen in Q4 2023 and held it in 7 quarters.
  • New Century Financial Group's Amgen position peaked at $1.16M in Q3 2024.
  • 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on New Century Financial Group's 13F filing for Q3 2025, filed 22 Oct 2025.